The international law firm Greenberg Traurig, LLP announced that Ginger Heyman Pigott has joined the Los Angeles office as a shareholder. Pigott will work closely with Lori G. Cohen, chair of Greenberg Traurig’s national Pharmaceutical, Medical Device & Health Care Litigation Practice Group and co-chair of the firm’s Atlanta Litigation Practice. Pigott was previously a partner at Reed Smith. She represents national and international pharmaceutical and medical device companies in products liability and commercial litigation matters.

“I am excited by the opportunity to continue to build my practice at Greenberg Traurig and to work with and help lead the growing Pharmaceutical, Medical Device & Health Care Litigation Practice,” said Pigott. “The firm has an excellent geographic platform across the United States, as well as strong global capabilities. With approximately 1,800 lawyers and 33 offices, Greenberg Traurig is well positioned to serve my clients now and in the future.”

“We are extremely pleased that Ginger has joined Greenberg Traurig. She is a talented products liability litigator and brings a wealth of experience to our pharmaceutical and medical device clients on the west coast, as well as nationally,” said Cohen. “Our Pharmaceutical, Medical Device & Health Care Litigation Practice has grown tremendously during the last few years, in both the clients we represent and the matters we handle, and we are excited and enthusiastic about new shareholders, like Ginger, wanting to join our team.”

Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Practice Group has more than 90 attorneys. The team was recently selected as a 2011 Products Liability Practice of the Year by Law360. Click here to view the Law360 profile. The firm’s national Products Liability Practice is also recognized in the 2011 edition of the Chambers and Partners USA Guide, an annual listing of the leading business lawyers and law firms in the world, and in the 2010 edition of Legal 500: United States.

“In addition to her litigation experience, Ginger also brings a deep understanding of the regulatory environment, which is vital to successfully navigating the increasingly complex needs of her clients,” said Jeff Scott, co-managing shareholder of the firm’s Los Angeles office. “We look forward to the many contributions we know that Ginger will make to our office and the national pharmaceutical and medical device litigation practice.”

Pigott’s primary focus in recent years has been the defense of medical device and pharmaceutical product liability lawsuits, ranging from diabetes management products to spinal, neurological and cardiovascular products, as well as implantable medical devices for various indications. She also focuses on external medical devices and equipment, pharmaceutical drugs, nutraceuticals and biologics. Pigott routinely consults with clients in a variety of industries regarding litigation exposure relating to product launches. This includes instructions for use, general labeling and other product liability issues.

A frequent author and lecturer, Pigott’s work has been published in The Los Angeles Daily Journal, San Francisco Daily Journal, Tort & Insurance Law Journal and Food and Drug Law Institute. She has presented on various topics at Legal Tech West, the Defense Research Institute Annual Meeting, Legal Marketing Association conferences and the American Conference Institute’s 3rd Annual E-Discovery and Litigation Readiness for Life Sciences conference. Pigott received her B.A., with honors, from the University of Michigan and her J.D., with honors, from Loyola University of Chicago Law School.

www.gtlaw.com